References

Boot E, Óskarsdóttir S, Loo JCY Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023; 25:(3) https://doi.org/10.1016/j.gim.2022.11.012

Chawner SJRA, Paine AL, Dunn MJ Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions. JCPP Adv. 2023; https://doi.org/10.1002/jcv2.12162

Everaert E, Vorstman JAS, Selten IS Executive functioning in preschoolers with 22q11.2 deletion syndrome and the impact of congenital heart defects. J Neurodev Disord. 2023; 15 https://doi.org/10.1186/s11689-023-09484-y

Kerin L, McNicholas F, Lawlor A Hearing the lived experience of young women with a rare genetic disorder 22q11.2DS regarding integrated care. Int J Integr Care. 2017; 17:(5) https://doi.org/10.5334/ijic.3537

Lawlor A, Kerin L, Orr D Developing integrated care in the context of rare chromosomal conditions: 22q11 Deletion Syndrome; A parent/clinician collaboration. Int J Integr Care. 2017; 17:(5) https://doi.org/10.5334/ijic.3525

Consensus Document. Consensus Document — Max Appeal.

McCormack S, Orr D, McNicholas F Integrated care for 22q11 deletion syndrome in Ireland: Meeting children's needs through enhanced care co-ordination. Arch Dis Child. 2019; 104:A1-A428 https://doi.org/10.1136/archdischild-2019-epa.172

Óskarsdóttir S, Boot E, Crowley TB Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023; 25 https://doi.org/10.1016/j.gim.2022.11.006

Lischner H, Punnett H, DiGeorge A Lymphocytes in Congenital Absence of the Thymus. Nature. 1967; 214:580-582 https://doi.org/10.1038/214580a0

O'Donoghue E, McAllister M, Rizzo R The experiences of families receiving a diagnosis of 22q11.2 deletion syndrome in Ireland. J Genet Couns. 2023; 32:618-634 https://doi.org/10.1002/jgc4.1667

Stafford N Angelo M DiGeorge. BMJ. 2009; 339 https://doi.org/10.1136/bmj.b5379

22q11.2 Deletion syndrome: What nurses need to know

02 March 2024
Volume 35 · Issue 3

Abstract

The chromosomal condition 22qDS encompasses diverse complex medical, developmental, and mental health problems. Here is what the latest research tells us

In 1965, Dr Max Cooper addressed the US Society for Pediatric Research to share experimental proof ‘that the lymphoid system is composed of two distinct cell populations’ (Stafford, 2009). In the audience, paediatric endocrinologist Dr Angelo DiGeorge (1921–2009) realised that Cooper's evidence explained the absence of cellular immunity despite the presence of antibody-producing cells in three athymic children whom DiGeorge had attended at Philadelphia's St Christopher's Hospital. In 1967, the DiGeorge syndrome entered the medical lexicon (Lischner et al, 1967). More widely known as 22q11.2 Deletion syndrome (22qDS), it is the most common chromosomal condition after Down syndrome.

Dr Suzanne Kelleher is a consultant general paediatrician working at Ireland's largest acute paediatric hospital – Children's Health Ireland, Crumlin – and in 2017 she established the national 22qDS clinic for children.

Dr Kelleher told Practice Nursing that 22qDS encompasses diverse complex medical, developmental, and mental health problems, with a prevalence of between 1 in 2000 and 1 in 4000 live births. ‘Given Ireland's current birthrate of just under 60,000 births there should be 15 to 30 babies born annually,’ she says, ‘yet based on the current population attending the 22qDS clinic it's likely that many children remain undiagnosed.’ Children born with 22qDS-associated congenital anomalies, like cardiac problems and cleft palate, are usually diagnosed in infancy, says Dr Kelleher. ‘However, there is a cohort of children who may present to their GP with, for instance, chronic constipation, anxiety, recurrent infections, scoliosis, or poor growth; their dentist (enamel hypoplasia, delayed eruption of dentition, severe dental caries); primary care therapist (speech delay, autistic features, ADHD); or may struggle at school (social anxiety, specific and generalised learning difficulties). These represent opportunities to refer for assessment and genetic testing but may not be considered.’

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month